Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2013-11-21 05:50 2013-11-20 RLYP N/A HUNT RONALD Director, Other Other BUY $11.00 185,978 $2,045,758 2,114,890 +9.6%
2013-11-21 01:33 2013-11-18 SAEX N/A ROSENFELD ERIC Director, 10% owner Other BUY $7.32 147,357 $1,078,697 1,339,731 +12.4%
2013-11-21 03:13 2013-11-20 RLYP N/A ROCKLAGE SCOTT M Director, 10% owner Other BUY $11.00 363,328 $3,996,608 2,418,066 +17.7%
2013-11-21 05:51 2013-11-20 RLYP N/A New Leaf Ventures I, L.P. Director, Other Other BUY $11.00 185,978 $2,045,758 2,114,890 +9.6%
2013-11-21 03:31 2013-11-20 RLYP N/A SILVERSTEIN JONATHAN Director, 10% owner Other BUY $11.00 712,192 $7,834,112 9,941,551 +7.7%
2013-11-21 03:23 2013-11-20 RLYP N/A ORBIMED ADVISORS LLC 10% owner Other BUY $11.00 712,192 $7,834,112 9,941,551 +7.7%
2013-11-21 01:49 2013-11-18 N/A N/A Silver Point Capital L.P. 10% owner Other BUY $46.50 25,000 $1,162,500 2,023,883 +1.3%
2013-11-20 00:22 2013-11-15 LMOS N/A Edidin Eric J 10% owner Other BUY $20.00 205,000 $4,100,000 2,554,138 +8.7%
2013-11-20 00:27 2013-11-18 DRC N/A MACAULAY WILLIAM E Director Other BUY $58.99 52,070 $3,071,609 223,496 +30.4%
2013-11-19 02:30 2013-03-25 VNRX VOLITIONRX LTD Innes Guy Archibald Director In Vitro & In Vivo Diagnostic Substances BUY $104,566.86 63,169 $6,605,383,701 932,095 +7.3%
2013-11-19 01:06 2013-11-15 FI EXPRO GROUP HOLDINGS N.V. Mosing Donald K. Director, Officer, 10% owner - See Remarks Oil & Gas Field Services, NEC BUY $25.48 70,000 $1,783,460 95,000 +280.0%
2013-11-18 15:59 2013-11-14 EPZM N/A Viswanathan Ravi 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:56 2013-11-14 EPZM N/A NEW ENTERPRISE ASSOCIATES 13 LP 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-19 04:03 2013-11-14 HCOM N/A TWIN HAVEN SPECIAL OPPORTUNITIES FUND III, L.P. 10% owner Other BUY $27.16 82,947 $2,253,222 1,440,000 +6.1%
2013-11-19 03:26 2013-11-14 ZINC N/A Dalal Street, LLC 10% owner Other BUY $13.98 248,575 $3,473,836 6,253,109 +4.1%
2013-11-18 15:59 2013-11-14 EPZM N/A Weller Harry R 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:57 2013-11-14 EPZM N/A DRANT RYAN D 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-19 00:29 2013-11-14 HMHC N/A Anchorage Capital Group, L.L.C. 10% owner Other BUY $14.00 72,818 $1,019,452 17,548,140 +0.4%
2013-11-18 15:57 2013-11-14 EPZM N/A BASKETT FOREST 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:58 2013-11-14 EPZM N/A KOLLURI KRISHNA KITTU 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:58 2013-11-14 EPZM N/A SANDELL SCOTT D 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:57 2013-11-14 EPZM N/A KERINS PATRICK J 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:58 2013-11-14 EPZM N/A MOTT DAVID M Director, 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:56 2013-11-14 EPZM N/A BARRETT M JAMES 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-18 15:56 2013-11-14 EPZM N/A BARRIS PETER J 10% owner Other BUY $19.68 406,500 $7,997,969 406,500 +100.0%
2013-11-16 00:09 2013-11-14 EFC Ellington Financial Inc. Vranos Michael W Director, Officer, 10% owner - Co-Chief Investment Officer Real Estate BUY $23.28 500,000 $11,637,500 514,294 +3,498.0%
2013-11-16 03:13 2013-11-13 AGYS Agilysys Inc. MAK CAPITAL ONE LLC 10% owner Services-Computer Integrated Systems Design BUY $11.62 1,115,805 $12,969,336 5,284,648 +26.8%
2013-11-16 00:46 2013-11-13 INWK N/A Sagard Capital Partners, L.P. 10% owner Other BUY $6.33 201,900 $1,278,027 7,015,225 +3.0%
2013-11-15 16:17 2013-11-13 RSSS Research Solutions, Inc. BRISTOL INVESTMENT FUND LTD 10% owner Services-Business Services, NEC BUY $325,000.00 162,500 $52,812,500,000 4,783,910 +3.5%
2013-11-15 22:14 2013-11-13 NHF NEXPOINT DIVERSIFIED REAL ESTATE TRUST HIGHLAND CAPITAL MANAGEMENT LP Other Real Estate Investment Trusts BUY $8.79 113,799 $1,000,361 113,799 +100.0%
2013-11-16 01:56 2013-11-13 SNTA MADRIGAL PHARMACEUTICALS, INC. Kovner Bruce Director, 10% owner Pharmaceutical Preparations BUY $3.75 5,000,000 $18,750,000 7,649,803 +188.7%
2013-11-15 22:51 2013-05-08 DUNR N/A TPG Opportunities Advisors, Inc. 10% owner Other BUY $1.60 1,777,448 $2,843,917 9,747,466 +22.3%
2013-11-16 05:00 2013-11-13 N/A N/A Silver Point Capital L.P. 10% owner Other BUY $43.57 107,162 $4,668,673 1,998,883 +5.7%
2013-11-15 03:43 2013-11-12 ACW N/A Cetus Capital II, LLC 10% owner Other BUY $3.23 500,839 $1,616,808 460,788 +100.0%
2013-11-15 00:22 2013-11-12 MLNX N/A Baharav Dov Director Other BUY $34.64 57,739 $1,999,969 66,906 +629.9%
2013-11-15 00:13 2013-11-12 SDOI N/A Becker Drapkin Management, L.P. 10% owner Other BUY $1.10 1,981,930 $2,176,556 709,234 +100.0%
2013-11-15 02:53 2013-11-12 HMTVA N/A Luxor Capital Group, LP 10% owner Other BUY $9.68 105,375 $1,019,503 1,388,529 +8.2%
2013-11-15 00:33 2013-11-12 KPTI Karyopharm Therapeutics Inc. PAKIANATHAN DEEPIKA Director Pharmaceutical Preparations BUY $16.00 312,500 $5,000,000 20,337 +100.0%
2013-11-15 01:29 2013-11-08 CHK EXPAND ENERGY Corp DUNHAM ARCHIE W Director Crude Petroleum & Natural Gas BUY $25.86 200,000 $5,171,600 1,052,586 +23.5%
2013-11-15 04:38 2013-11-12 AMED N/A KKR Asset Management LLC 10% owner Other BUY $13.89 946,500 $13,150,482 4,411,115 +27.3%
2013-11-15 04:31 2013-11-13 TNDM TANDEM DIABETES CARE INC HLM VENTURE PARTNERS II, L.P. 10% owner Surgical & Medical Instruments & Apparatus BUY $15.00 200,000 $3,000,000 200,000 +100.0%
2013-11-13 18:22 2013-11-12 OHI OMEGA HEALTHCARE INVESTORS INC KORMAN BERNARD J Director Real Estate Investment Trusts BUY $31.15 46,070 $1,435,081 576,526 +8.7%
2013-11-14 01:00 2013-11-13 NCFT N/A Reilly Christopher K. Director Other BUY $16.00 5,521,325 $88,341,200 5,521,325 +100.0%
2013-11-14 00:16 2013-11-13 BANX ArrowMark Financial Corp. Siegel Joshua S. Director, Officer - Chief Executive Officer Other BUY $1,037,750.00 41,510 $43,077,002,500 45,511 +1,037.5%
2013-11-14 00:14 2013-11-13 BANX ArrowMark Financial Corp. Shilowitz George Director, Officer - President Other BUY $1,037,750.00 41,510 $43,077,002,500 45,510 +1,037.8%
2013-11-13 22:23 2013-11-12 AGCO AGCO Corporation SRINIVASAN MALLIKA Director Farm Machinery & Equipment BUY $57.78 119,773 $6,920,484 5,568,236 +2.2%
2013-11-14 02:04 2013-11-11 AGYS Agilysys Inc. MAK CAPITAL ONE LLC 10% owner Services-Computer Integrated Systems Design BUY $11.79 743,870 $8,770,227 5,284,648 +16.4%
2013-11-14 01:59 2013-11-11 ZINC N/A Dalal Street, LLC 10% owner Other BUY $13.96 190,921 $2,665,601 6,004,534 +3.3%
2013-11-14 00:06 2013-11-08 JGW N/A JLL JGW Distribution, LLC Director, 10% owner Other BUY $13.13 1,500,000 $19,687,500 1,500,000 +100.0%
2013-11-14 00:52 2013-11-11 IQNT N/A Hynes James P Director Other BUY $12.20 200,000 $2,439,940 593,275 +50.9%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.